Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totaling 120,253 shares, a growth of 216.6% from the April 30th total of 37,978 shares. Based on an average daily volume of 38,663 shares, the days-to-cover ratio is currently 3.1 days.

Conduit Pharmaceuticals Stock Up 1.4%

CDTTW stock opened at $0.01 on Friday. Conduit Pharmaceuticals has a fifty-two week low of $0.01 and a fifty-two week high of $0.02. The firm’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

Get Conduit Pharmaceuticals alerts:

About Conduit Pharmaceuticals

(Get Free Report)

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.

Featured Stories

• Five stocks we like better than Conduit Pharmaceuticals
• Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
• Salesforce Stock Finds Support as AI Momentum Builds
• Dollar Tree Keeps Winning After Family Dollar Divorce
• Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet

Receive News & Ratings for Conduit Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conduit Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.